Incorporating new diagnostic schemas, genetics, and proteinopathy into the evaluation of frontotemporal degeneration

Tiffany W. Chow, Ammar A. Alobaidy

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose of Review: Within the continuously growing body of knowledge in the field of dementia, frontotemporal degeneration stands out in importance as the second most common cause of early-onset dementia after Alzheimer disease. Neurologists, neuropsychologists, and speech pathologists are particularly involved in the diagnosis and recognition of etiologies for patients with deficits in frontal lobe function and language.Recent Findings: The recent discovery of a novel mutant gene (C9ORF72) and the new nomenclature adopted for subclassification have significantly promoted our understanding of this disorder.Summary: This article relates the most recent consensus criteria for diagnosis of the two forms of frontotemporal degeneration (ie, behavioral and primary progressive aphasia variants) to basic neurologic principles and remind clinicians of the neuropsychiatric and neuroradiologic components that clarify frontotemporal degeneration diagnoses and guide management.

Original languageEnglish
Pages (from-to)438-456
Number of pages19
JournalCONTINUUM Lifelong Learning in Neurology
Volume19
Issue number2
DOIs
Publication statusPublished - Apr 2013
Externally publishedYes

Fingerprint

Primary Progressive Aphasia
Frontotemporal Dementia
Frontal Lobe
Terminology
Nervous System
Dementia
Consensus
Alzheimer Disease
Language
Genes
Recognition (Psychology)
Pathologists
Neurologists

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

@article{9e289d26b0e84f90a089de28b3be958b,
title = "Incorporating new diagnostic schemas, genetics, and proteinopathy into the evaluation of frontotemporal degeneration",
abstract = "Purpose of Review: Within the continuously growing body of knowledge in the field of dementia, frontotemporal degeneration stands out in importance as the second most common cause of early-onset dementia after Alzheimer disease. Neurologists, neuropsychologists, and speech pathologists are particularly involved in the diagnosis and recognition of etiologies for patients with deficits in frontal lobe function and language.Recent Findings: The recent discovery of a novel mutant gene (C9ORF72) and the new nomenclature adopted for subclassification have significantly promoted our understanding of this disorder.Summary: This article relates the most recent consensus criteria for diagnosis of the two forms of frontotemporal degeneration (ie, behavioral and primary progressive aphasia variants) to basic neurologic principles and remind clinicians of the neuropsychiatric and neuroradiologic components that clarify frontotemporal degeneration diagnoses and guide management.",
author = "Chow, {Tiffany W.} and Alobaidy, {Ammar A.}",
year = "2013",
month = "4",
doi = "10.1212/01.CON.0000429173.35439.9c",
language = "English",
volume = "19",
pages = "438--456",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Incorporating new diagnostic schemas, genetics, and proteinopathy into the evaluation of frontotemporal degeneration

AU - Chow, Tiffany W.

AU - Alobaidy, Ammar A.

PY - 2013/4

Y1 - 2013/4

N2 - Purpose of Review: Within the continuously growing body of knowledge in the field of dementia, frontotemporal degeneration stands out in importance as the second most common cause of early-onset dementia after Alzheimer disease. Neurologists, neuropsychologists, and speech pathologists are particularly involved in the diagnosis and recognition of etiologies for patients with deficits in frontal lobe function and language.Recent Findings: The recent discovery of a novel mutant gene (C9ORF72) and the new nomenclature adopted for subclassification have significantly promoted our understanding of this disorder.Summary: This article relates the most recent consensus criteria for diagnosis of the two forms of frontotemporal degeneration (ie, behavioral and primary progressive aphasia variants) to basic neurologic principles and remind clinicians of the neuropsychiatric and neuroradiologic components that clarify frontotemporal degeneration diagnoses and guide management.

AB - Purpose of Review: Within the continuously growing body of knowledge in the field of dementia, frontotemporal degeneration stands out in importance as the second most common cause of early-onset dementia after Alzheimer disease. Neurologists, neuropsychologists, and speech pathologists are particularly involved in the diagnosis and recognition of etiologies for patients with deficits in frontal lobe function and language.Recent Findings: The recent discovery of a novel mutant gene (C9ORF72) and the new nomenclature adopted for subclassification have significantly promoted our understanding of this disorder.Summary: This article relates the most recent consensus criteria for diagnosis of the two forms of frontotemporal degeneration (ie, behavioral and primary progressive aphasia variants) to basic neurologic principles and remind clinicians of the neuropsychiatric and neuroradiologic components that clarify frontotemporal degeneration diagnoses and guide management.

UR - http://www.scopus.com/inward/record.url?scp=84876361036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876361036&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000429173.35439.9c

DO - 10.1212/01.CON.0000429173.35439.9c

M3 - Article

VL - 19

SP - 438

EP - 456

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 2

ER -